Premium
Summary of the BSR biological DMARD safety guidelines
Author(s) -
Chaplin Steve
Publication year - 2019
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1749
Subject(s) - medicine , intensive care medicine , alternative medicine , family medicine , pathology
The British Society for Rheumatology (BSR) recently published new evidence‐based guidelines on the safe prescribing of biological DMARDs for inflammatory arthritis. This article provides a summary of their recommendations on screening, monitoring and considering co‐morbidities prior to and during treatment.